By Giulia Corso|2024-10-18T08:52:00+00:00October 18th, 2024|Extracellular Vesicles, publication|
Newly published article on affinity-based purification of recombinant EVs October 18th, 2024, Vienna, AustriaA recent collaborative work has been published showcasing the
By Giulia Corso|2024-09-26T11:26:20+00:00September 26th, 2024|conferences, EV cell factories, EVscale, Extracellular Vesicles, mesenchymal stromal cells|
We participated to the ASEV and CzeSEV 2024 meeting in Vienna, Austria September 26th, 2024, Vienna, Austria We participated to the
By Giulia Corso|2024-09-26T11:26:47+00:00September 5th, 2024|collaboration, EU funded project, recent highlights, telomerized cells|
New review published by LifeSaver Project Consortium September 5th, 2024, Vienna, Austria The LifeSaver Project Consortium has published a comprehensive review
By Giulia Corso|2024-09-26T11:27:26+00:00August 19th, 2024|distributors, recent highlights|
Partnering with Chameleon Science August 19th, 2024, Vienna, Austria We are thrilled to announce that we have partnered with the new
By Giulia Corso|2024-09-26T11:28:18+00:00August 13th, 2024|cell line development, recent highlights cell line development, telomerized cells|
Newly released telomerized amniotic epithelial cells August 13th, 2024, Vienna, Austria We are thrilled to announce the newest addition to our
By Giulia Corso|2024-09-26T11:28:45+00:00June 27th, 2024|cell line development, conferences, EV cell factories, extracellular vesicles, organ-on-a-chip|
Evercyte highlights immortalized cell technology at SelectBIO Rotterdam 2024 June 27th, 2024, Vienna, Austria We participated as technology spotlight speakers at
By Giulia Corso|2024-05-29T13:40:27+00:00May 23rd, 2024|Extracellular vesicles, mesenchymal stromal cells, recent highlights EV, telomerized cells|
Recent publication showcasing our ASC/TERT1 cells as EV production system May 23rd, 2024, Vienna, AustriaOur telomerized human adipose derived MSC (ASC/TERT1, also known in
By Giulia Corso|2024-09-26T11:29:18+00:00April 29th, 2024|EVscale, Extracellular vesicles, recent highlights EV|
Evercyte proudly introduces the EVscale™ platform April 29th, 2024, Vienna, Austria The collaborative effort of Evercyte, Phoenestra, and TAmiRNA has yielded the EVscale™ platform,
By Giulia Corso|2024-09-26T11:49:21+00:00February 16th, 2024|PODO/TERT256, telomerized cells|
Recent publication showcasing our PODO/TERT256 telomerized cell line February 16th, 2024, Vienna, Austria Our telomerized human podocyte cells (PODO/TERT256) were employed in an
By Giulia Corso|2024-09-26T11:29:37+00:00December 7th, 2023|3Rs, cell line development, conferences, GCCP|
Evercyte contributing to reduce animal testing at key events December 7th, 2023, Vienna, Austria We participated as an invited attendee at
